Skip to main content
Debate: Optimal Treatment for HER2-Positive Colorectal Cancer After First-Line Treatment: Chemotherapy or HER2-Positive Agents? HER2-Positive Agents.
Thursday, October 28, 2021
12:58 PM – 1:06 PM
Kanwal PS Raghav, MD, MBBS
The University of Texas MD Anderson Cancer Center
This talk is supported by educational grants provided by Bayer HealthCare Pharmaceuticals, Inc., Pfizer
Inc. and Taiho Oncology, Inc.